Literature DB >> 21234682

The relationship between consumer insight and provider-consumer agreement regarding consumer's quality of life.

Ilanit Hasson-Ohayon1, David Roe, Shlomo Kravetz, Itamar Levy-Frank, Taly Meir.   

Abstract

This study examined the relationship between insight and mental health consumers and providers agreement regarding consumers rated quality of life (QoL). Seventy mental health consumers and their 23 care providers filled-out parallel questionnaires designed to measure consumer QoL. Consumers' insight was also assessed. For most QoL domains, agreement between consumers and providers was higher for persons with high insight. For the Psychological well being dimension a negative correlation was uncovered for persons with low insight indicating disagreement between consumer and provider. These findings are discussed within the context of the literature on insight and agreement between consumer and provider as related to the therapeutic alliance.

Entities:  

Mesh:

Year:  2011        PMID: 21234682     DOI: 10.1007/s10597-011-9380-2

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  26 in total

Review 1.  The therapeutic relationship in the treatment of severe mental illness: a review of methods and findings.

Authors:  Rosemarie McCabe; Stefan Priebe
Journal:  Int J Soc Psychiatry       Date:  2004-06

2.  The working alliance and consumer case management.

Authors:  P Solomon; J Draine; M A Delaney
Journal:  J Ment Health Adm       Date:  1995

3.  Assessing the outcome of community-based psychiatric care: building a feedback loop from 'real world' health services research into clinical practice.

Authors:  A Lasalvia; M Ruggeri
Journal:  Acta Psychiatr Scand Suppl       Date:  2007

4.  Factors influencing subjective quality of life in patients with schizophrenia and other mental disorders: a pooled analysis.

Authors:  Stefan Priebe; Ulrich Reininghaus; Rosemarie McCabe; Tom Burns; Mona Eklund; Lars Hansson; Ulrich Junghan; Thomas Kallert; Chijs van Nieuwenhuizen; Mirella Ruggeri; Mike Slade; Duolao Wang
Journal:  Schizophr Res       Date:  2010-05-18       Impact factor: 4.939

5.  Processes of disengagement and engagement in assertive outreach patients: qualitative study.

Authors:  Stefan Priebe; Jay Watts; Mike Chase; Aleksandra Matanov
Journal:  Br J Psychiatry       Date:  2005-11       Impact factor: 9.319

6.  A new patient focused index for measuring quality of life in persons with severe and persistent mental illness.

Authors:  M Becker; R Diamond; F Sainfort
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

7.  Different ways of being aware of a psychiatric disability: a multifunctional narrative approach to insight into mental disorder.

Authors:  David Roe; Shlomo Kravetz
Journal:  J Nerv Ment Dis       Date:  2003-07       Impact factor: 2.254

8.  Taking the perspective of the other contributes to awareness of illness in schizophrenia.

Authors:  Robyn Langdon; Philip Ward
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

9.  Judgments of quality of life of individuals with severe mental disorders: Patient self-report versus provider perspectives.

Authors:  F Sainfort; M Becker; R Diamond
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Best practices: A systematic approach to the management of patients who refuse medications in an assertive community treatment team setting.

Authors:  Christopher Tam; Samuel Law
Journal:  Psychiatr Serv       Date:  2007-04       Impact factor: 3.084

View more
  2 in total

1.  Social functioning in schizophrenia: Comparing laboratory-based assessment with real-world measures.

Authors:  Danielle B Abel; Kyle S Minor
Journal:  J Psychiatr Res       Date:  2021-04-30       Impact factor: 5.250

2.  Metacognition moderates the relationship between self-reported and clinician-rated motivation in schizophrenia.

Authors:  Lauren Luther; Kelsey A Bonfils; Melanie W Fischer; Annalee V Johnson-Kwochka; Michelle P Salyers
Journal:  Schizophr Res Cogn       Date:  2019-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.